Skip to content

Clinical efficacy and safety of Isha Balm

An open label clinical study to evaluate the safety and efficacy of Isha Balm an ayurvedic proprietary topical application for mild to moderate headache and nasal symptoms

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011819
Enrollment
30
Registered
2018-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Headache

Interventions

Intervention1: Isha balm: External application quantity as required 1-3 days

Sponsors

Isha Arogya pvt ltd
Lead Sponsor
DrSRajesh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1Patients attending the clinic in the age group of 12 years and above and both the sexes included 2 Patients provisionally diagnosed to have viral prodrome, common cold, acute sinusitis, tension headache, migraine headache with the symptom of headache are included the study with their consent.

Exclusion criteria

Exclusion criteria: 1 past medical records needing neurological evaluation for headache 2known cases of hypertention, and those getting treatment complications of uncontrolled hypertention 3having ophthalmic complaints 4Patients with serious co-morbid illnesses such as known cardiac vascular disease, cancer induced pain, injuries due to fall or accidents, systemic illness like SLE,etc • Patients below the age of 12 years and above 60 years. • Patients who are not willing to give informed written consent.

Design outcomes

Primary

MeasureTime frame
Relief from headacheTimepoint: 3 days

Secondary

MeasureTime frame
Relief from Nasal blockTimepoint: 3 days

Countries

India

Contacts

Public ContactMaa Induba

Isha Arogya Health Centre

rajesh.srinivasan@ishaarogya.org9942196781

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026